Results 311 to 320 of about 194,651 (386)

Plasma p-tau species are elevated in presymptomatic and symptomatic neuronal intranuclear inclusion disease. [PDF]

open access: yesEBioMedicine
Zhang S   +38 more
europepmc   +1 more source

Proteomic profile of CSF obtained at the time of diagnosis determines amyotrophic lateral sclerosis progression and survival: CXCL7 levels in disease prognosis and survival

open access: yesBrain Pathology, EarlyView.
Untargeted multiomic profiling of cerebrospinal fluid reveals that proteomic, but not lipidomic, signatures robustly distinguish ALS patients from controls and stratify individuals by survival, highlighting marked molecular differences between short survival and long survival disease.
Sergio Roca‐Pereira   +19 more
wiley   +1 more source

Clinical and molecular features of primary gliosarcoma with digital spatial whole‐transcriptome analysis of glial and mesenchymal components

open access: yesBrain Pathology, EarlyView.
We report the clinical and genetic features of an institutional cohort of primary adult gliosarcomas compared to glioblastoma. We performed spatial whole‐transcriptome analysis on glial and sarcomatous regions of four cases to compare gene expression profiles and validated differential protein expression for two markers in tissue sections.
Matthew D. Wood   +6 more
wiley   +1 more source

A 17‐year‐old male with chronic epilepsy status post remote functional hemispherectomy

open access: yes
Brain Pathology, EarlyView.
Claire Voyles   +3 more
wiley   +1 more source

Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Differential Biomarkers of Response to Dimethyl Fumarate and Ocrelizumab in Multiple Sclerosis. [PDF]

open access: yesInt J Mol Sci
Mingione A   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy